Buy Tesamorelin 20mg: Synthetic GHRH Analog for Metabolic & GH Research

Tesamorelin (20mg) is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate endogenous growth hormone (GH) release. Extensively studied in metabolic research, it supports investigations into visceral fat reduction, hormone regulation, energy balance, metabolic health, and potential effects on aging processes in experimental models.

Molecular Formula: C221H366N72O67S Molecular Weight: 5135.9 g/mol (free base) Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Tesamorelin?

Tesamorelin is a 44-amino-acid polypeptide modified with a trans-3-hexenoyl group at the N-terminus for enhanced stability and resistance to enzymatic degradation compared to native GHRH. It selectively binds to GHRH receptors on pituitary somatotrophs, promoting pulsatile GH secretion and subsequent IGF-1 elevation in research settings.

Clinical and preclinical studies have positioned Tesamorelin as a key compound for modeling GH-mediated pathways, particularly in lipodystrophy analogs, adipose tissue distribution, and endocrine-metabolic interactions.

Mechanism of Action in Research

Tesamorelin stimulates the pituitary to release growth hormone in a physiological, pulsatile manner, leading to:

• Increased IGF-1 levels
• Enhanced lipolysis, especially in visceral adipose tissue
• Modulation of metabolic parameters like insulin sensitivity and lipid profiles
• Potential influences on cellular repair, energy expenditure, and age-related endocrine decline

These effects make it suitable for studies exploring GH/IGF-1 axis dynamics without direct GH administration.

Key Research Findings and Applications

Tesamorelin excels in targeted metabolic and endocrine investigations.

Visceral Fat Reduction Models

Research demonstrates significant reductions in visceral adipose tissue (VAT) in models of excess abdominal fat, with sustained effects on body composition and fat distribution.

Hormone Regulation and GH/IGF-1 Axis

Studies focus on its ability to elevate GH and IGF-1 levels dose-dependently, offering insights into hormone signaling, feedback loops, and pituitary function.

Aging, Energy Balance, and Metabolic Health

Explorations include potential geroprotective roles, impacts on energy metabolism, mitochondrial function, and age-associated metabolic shifts in experimental systems.

Additional Areas

Broader applications cover lipodystrophy analogs, HIV-associated metabolic research models, and comparative studies with other GHRH analogs or secretagogues.

Research Applications

The 20mg vial supports:

• In-vitro and in-vivo GH secretion assays
• Adipose tissue metabolism and lipolysis studies
• Endocrine aging and metabolic syndrome models
• Reconstitution for dose-response or chronic exposure experiments

Common lab reconstitution: Use bacteriostatic water to achieve desired concentrations for precise administration in protocols.

Why Choose 99% Pure Tesamorelin 20mg?

Our Tesamorelin provides ≥99% purity for reliable, reproducible outcomes in receptor binding, GH release kinetics, and metabolic endpoint measurements. Third-party tested and lyophilized for optimal stability.

In summary, Tesamorelin 20mg is a high-quality synthetic GHRH analog for advanced research into growth hormone stimulation, visceral fat reduction, metabolic regulation, energy balance, and aging-related endocrine processes. Advance your metabolic and hormonal studies with this potent research peptide.

Latest Testing: Link to Report